School of Medicine


Showing 1-7 of 7 Results

  • Gary Schoolnik

    Gary Schoolnik

    Professor of Medicine (Infectious Diseases), Emeritus

    Current Research and Scholarly Interests Structure-function analysis of bacterial adhesion proteins and toxins; design and synthesis of synthetic antigens; immunobiology of human papillomaviruses

  • Jake Scott

    Jake Scott

    Clinical Assistant Professor, Medicine - Infectious Diseases

    Bio Dr. Jake Scott is a board-certified infectious diseases specialist. He provides general infectious diseases care in the inpatient and outpatient settings and his special interests include COVID-19, coccidiomycosis, multidrug-resistant organisms, HIV, and HIV pre-exposure prophylaxis. He works with patients from diverse backgrounds to provide compassionate, high-quality care aligned with their needs.

    Dr. Scott was born and raised in the Bay Area and was inspired to pursue a career in medicine after working as an HIV test counselor in San Francisco. He studied literature and creative writing in college and values the narrative aspect of medicine and the importance of drawing out the story behind the diagnosis.

    One of Dr. Scott’s passions is teaching. He regularly works with Stanford residents and students and has lectured on various infectious disease-related topics, such as COVID-19, fever of unknown origin, and the dangers of antibiotic overuse, especially as it contributes to the rising threat of multidrug-resistant infections. He is also committed to expanding awareness of infectious diseases outside of the hospital and university through public presentations in the community and media interviews.
    He is co-medical director of the Antibiotic Stewardship Program at Stanford Health Care – ValleyCare in Pleasanton and member of the Infection Control Committee.

    In his spare time, Dr. Scott enjoys rock climbing, hiking, and spending time with his two young children.

  • Robert W. Shafer

    Robert W. Shafer

    Professor (Research) of Medicine (Infectious Diseases) and, by courtesy, of Pathology

    Current Research and Scholarly Interests My group’s research is on the mechanisms and consequences of virus evolution with a focus on HIV therapy and drug resistance. We maintain a public HIV drug resistance database (http://hivdb.stanford.edu) as a resource for HIV drug resistance surveillance, interpreting HIV drug resistance tests, and HIV drug development. Our paramount goal is to inform HIV treatment and prevention policies by identifying the main factors responsible for the emergence and spread of drug resistance.

  • Upinder Singh

    Upinder Singh

    Professor of Medicine (Infectious Diseases & Geographic Medicine) and of Microbiology and Immunology

    Current Research and Scholarly Interests Our lab elucidates the molecular basis of pathogenesis of the protozoan parasite Entamoeba histolytica. We use genetic and genomic approaches to identify novel virulence determinants and to characterize the global epidemiology of the parasite.

  • David A. Stevens

    David A. Stevens

    Professor of Medicine, Emeritus

    Current Research and Scholarly Interests Immunology and chemotherapy of human fungal diseases, particularly coccidioidomycosis (Valley Fever) in California and aspergillosis, and the parasitic disease, trypanosomiasis.

  • Aruna Subramanian

    Aruna Subramanian

    Clinical Professor, Medicine - Infectious Diseases

    Current Research and Scholarly Interests My research and scholarly interests have focused on tailoring antimicrobial prophylaxis in specific highly immunocompromised hosts depending on their specific infectious disease risks. I am interested in developing diagnostic algorithms and treatment protocols that will improve the quality of care in transplant and oncology patients.

    I also have an interest in training ID fellows in this very specialized area of patient care. To that end, we have started a new ICHS ID fellowship with a specialized curriculum and are developing supplemental educational materials to enhance this training, which can be implemented at other academic training centers.

Latest information on COVID-19